Participant flow35

How many started, completed or left each group, period by period.

21 to 35 of 35

Period	Milestone	Group	Participants
Overall Study	Per Protocol Set	Cebranopadol 100 µg	58
Overall Study	Per Protocol Set	Cebranopadol 300 µg	55
Overall Study	Per Protocol Set	Cebranopadol 600 µg	50
Overall Study	Per Protocol Set	Pregabalin	51
Overall Study	Per Protocol Set	Matching Placebo	49
Overall Study	COMPLETED	Cebranopadol 100 µg	52
Overall Study	COMPLETED	Cebranopadol 300 µg	41
Overall Study	COMPLETED	Cebranopadol 600 µg	27
Overall Study	COMPLETED	Pregabalin	51
Overall Study	COMPLETED	Matching Placebo	48
Overall Study	NOT COMPLETED	Cebranopadol 100 µg	14
Overall Study	NOT COMPLETED	Cebranopadol 300 µg	23
Overall Study	NOT COMPLETED	Cebranopadol 600 µg	38
Overall Study	NOT COMPLETED	Pregabalin	17
Overall Study	NOT COMPLETED	Matching Placebo	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01939366/flow?page=2